These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29519629)

  • 1. One year follow-up after treatment with CCH for Dupuytren's disease: A prospective view.
    Sanjuán-Cerveró R; Vazquez-Ferreiro P; Gómez-Herrero D; Carrera-Hueso FJ; Fikri-Banbrahim N
    Rev Esp Cir Ortop Traumatol (Engl Ed); 2018; 62(6):448-457. PubMed ID: 29519629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
    Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
    Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
    Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
    Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Dupuytren's disease using collagenase from Clostridium histolyticum].
    Martín-Ferrero MÁ; Simón-Pérez C; Rodríguez-Mateos JI; García-Medrano B; Hernández-Ramajo R; Brotat-García M
    Rev Esp Cir Ortop Traumatol; 2013; 57(6):398-402. PubMed ID: 24071041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of collagenase Clostridium histolyticum injection for Dupuytren's contracture in East-Asian population.
    Hatta T; Goto H; Sonofuchi K; Itoi E
    J Orthop Sci; 2019 May; 24(3):431-433. PubMed ID: 30392715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
    Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
    Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
    J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
    Hwee YK; Park D; Vinas M; Litts C; Friedman D
    Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
    McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B
    Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
    Badalamente MA; Hurst LC; Benhaim P; Cohen BM
    J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
    Sakai A; Zenke Y; Menuki K; Yamanaka Y; Tajima T; Tsukamoto M; Uchida S
    J Orthop Sci; 2019 May; 24(3):434-440. PubMed ID: 30392714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
    Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
    J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.
    Nordenskjöld J; Lauritzson A; Åkesson A; Atroshi I
    Acta Orthop; 2019 Dec; 90(6):517-522. PubMed ID: 31500473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
    Nayar SK; Pfisterer D; Ingari JV
    Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.
    Alberton F; Corain M; Garofano A; Pangallo L; Valore A; Zanella V; Adani R
    Musculoskelet Surg; 2014 Dec; 98(3):225-32. PubMed ID: 24254968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.
    Lauritzson A; Atroshi I
    BMJ Open; 2017 Mar; 7(3):e012943. PubMed ID: 28298365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
    Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
    Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium histolyticum as first-line treatment of Dupuytren's disease.
    Hartig-Andreasen C; Schroll L; Lange J
    Dan Med J; 2019 Feb; 66(2):. PubMed ID: 30722822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.